Segui
Javier Martín Broto
Javier Martín Broto
Sarcoma Medical Oncology Consultant, University Hospital Fundacion Jimenez Diaz
Email verificata su mustbesevilla.org
Titolo
Citata da
Citata da
Anno
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack, S Bonvalot, ...
Annals of Oncology 29, iv51-iv67, 2018
6392018
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a …
JS Gold, M Gönen, A Gutiérrez, JM Broto, X García-del-Muro, TC Smyrk, ...
The lancet oncology 10 (11), 1045-1052, 2009
5382009
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack, S Bonvalot, ...
Annals of Oncology 29, iv68-iv78, 2018
4112018
Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish …
J Martín, A Poveda, A Llombart-Bosch, R Ramos, JA López-Guerrero, ...
J Clin Oncol 23 (25), 6190-6198, 2005
3842005
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
PG Casali, S Bielack, N Abecassis, HT Aro, S Bauer, R Biagini, ...
Annals of Oncology 29, iv79-iv95, 2018
3472018
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label …
A Gronchi, S Ferrari, V Quagliuolo, JM Broto, AL Pousa, G Grignani, ...
The Lancet Oncology 18 (6), 812-822, 2017
3432017
An update on the management of sporadic desmoid-type fibromatosis: a European consensus initiative between Sarcoma Patients EuroNet (SPAEN) and European Organization for …
B Kasper, C Baumgarten, J Garcia, S Bonvalot, R Haas, F Haller, ...
Annals of Oncology 28 (10), 2399-2408, 2017
2542017
Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research …
X García-del-Muro, A López-Pousa, J Maurel, J Martín, J Martínez-Trufero, ...
Journal of Clinical Oncology 29 (18), 2528-2533, 2011
2472011
Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 cases
J Lasota, CL Corless, MC Heinrich, M Debiec-Rychter, R Sciot, ...
Modern pathology 21 (4), 476-484, 2008
2172008
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
WD Tap, H Gelderblom, E Palmerini, J Desai, S Bauer, JY Blay, T Alcindor, ...
The Lancet 394 (10197), 478-487, 2019
1972019
Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group
A Gronchi, S Frustaci, M Mercuri, J Martin, A Lopez-Pousa, P Verderio, ...
J Clin Oncol 30 (8), 850-856, 2012
1882012
Outcome of Patients with Platelet-Derived Growth Factor Receptor Alpha–Mutated Gastrointestinal Stromal Tumors in the Tyrosine Kinase Inhibitor EraAdvanced PDGFRA-Mutant GIST
PA Cassier, E Fumagalli, P Rutkowski, P Schöffski, M Van Glabbeke, ...
Clinical Cancer Research 18 (16), 4458-4464, 2012
1792012
Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group
S Stacchiotti, A Gronchi, P Fossati, T Akiyama, C Alapetite, M Baumann, ...
Annals of Oncology 28 (6), 1230-1242, 2017
1392017
Effect of doxorubicin plus olaratumab vs doxorubicin plus placebo on survival in patients with advanced soft tissue sarcomas: the ANNOUNCE randomized clinical trial
WD Tap, AJ Wagner, P Schöffski, J Martin-Broto, A Krarup-Hansen, ...
Jama 323 (13), 1266-1276, 2020
1322020
Time to definitive failure to the first tyrosine kinase inhibitor in localized GI stromal tumors treated with imatinib as an adjuvant: a European Organisation for Research and …
P Casali, A Le Cesne, AP Velasco, D Kotasak, P Rutkowski, ...
American Society of Clinical Oncology, 2015
1312015
GEIS guidelines for gastrointestinal sarcomas (GIST)
A Poveda, XG Del Muro, JA López-Guerrero, R Cubedo, V Martínez, ...
Cancer treatment reviews 55, 107-119, 2017
1152017
Giant cell tumour of bone: new treatments in development
A López-Pousa, JM Broto, T Garrido, J Vázquez
Clinical and Translational Oncology 17 (6), 419-430, 2015
1072015
A phase II trial of temozolomide as a 6‐week, continuous, oral schedule in patients with advanced soft tissue sarcoma: a study by the Spanish Group for Research on Sarcomas
X Garcia del Muro, A Lopez‐Pousa, J Martin, JM Buesa, ...
Cancer 104 (8), 1706-1712, 2005
1062005
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
A Gronchi, AB Miah, AP Dei Tos, N Abecassis, J Bajpai, S Bauer, ...
Annals of Oncology 32 (11), 1348-1365, 2021
972021
Tumor response assessment by modified Choi criteria in localized high‐risk soft tissue sarcoma treated with chemotherapy
S Stacchiotti, P Verderio, A Messina, C Morosi, P Collini, ...
Cancer 118 (23), 5857-5866, 2012
972012
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20